Evolving Therapeutic Landscape in Thyroid Cancer

Evolving Therapeutic Landscape in Thyroid Cancer

Episodes

Specialty:

All

Year:

All

EP. 1: Introduction: Radioactive Iodine-Refractory DTC

July 9th 2014

EP. 2: Determining Treatment for RAI-Refractory Thyroid Cancer

July 9th 2014

EP. 3: Available Treatment Options for RAI-Refractory DTC

July 9th 2014

EP. 4: Sequencing Therapies in Differentiated Thyroid Cancer

July 9th 2014

EP. 5: Patient Selection for Systemic Therapy in DTC

July 9th 2014

EP. 6: Role of the Endocrinologist in RAI-Refractory Thyroid Cancer

July 9th 2014

EP. 7: Case Study: Treating Papillary Thyroid Cancer

July 9th 2014

EP. 8: Managing Sorafenib-Related AEs in Thyroid Cancer

July 9th 2014

EP. 9: Diagnosis and Initial Treatment of MTC

July 9th 2014

EP. 10: Utilizing TKIs in Advanced Medullary Thyroid Cancer

July 9th 2014

EP. 11: Treatment Selection in Advanced MTC

July 9th 2014

EP. 12: Importance of Multidisciplinary Thyroid Cancer Care

July 9th 2014

Trending on OncLive

ASCO Issues First Guideline on ctDNA Testing in Solid Tumors and Lymphoma

Dr Wainberg on INCB161734 Activity in Refractory Pancreatic Cancer

ASCO Guideline Update Broadens First-Line Treatment Options for HER2+ Gastroesophageal Cancer

European Commission Approves Teclistamab Plus Daratumumab for R/R Myeloma

CAR T-Cell Therapy Continues to Make Its Case in Early Relapsed Myeloma